Intended for healthcare professionals

Rapid response to:

Clinical Review

Diagnosis of ovarian cancer

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h4443 (Published 01 September 2015) Cite this as: BMJ 2015;351:h4443

Rapid Response:

Re: Diagnosis of ovarian cancer

In respect of the prevention or delay of recurrence of ovarian cancer after treatment and remission there is anecdotal evidence that a daily intake of palmitoyl ascorbate (a safe food additive) can reduce the CA125 count and extend the periods of remission.

This is worthy of further research as the compound is cheap (<10 p / day) and freely available. Perhaps a group might feel able to consider it with a view to saving NHS funds.

Competing interests: No competing interests

06 September 2015
Andrew J C Carmichael
Retired dental surgeon
Parkinson's Improvement Programme
Preston